-2 overexpression in type II epithelial cells does not prevent hyperoxia-induced acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 299: L312-L322, 2010. First published April 9, 2010 doi:10.1152 doi:10. /ajplung.00212.2009 is an anti-apoptotic molecule preventing oxidative stress damage and cell death. We have previously shown that Bcl-2 is able to prevent hyperoxia-induced cell death when overexpressed in a murine fibrosarcoma cell line L929. We hypothesized that its specific overexpression in pulmonary epithelial type II cells could prevent hyperoxia-induced lung injury by protecting the epithelial side of the alveolo-capillary barrier. In the present work, we first showed that in vitro Bcl-2 can rescue murine pulmonary epithelial cells (MLE12) from oxygen-induced cell apoptosis, as shown by analysis of LDH release, annexin V/propidium staining, and caspase-3 activity. We then generated transgenic mice overexpressing specifically Bcl-2 in lung epithelial type II cells under surfactant protein C (SP-C) promoter (Tg-Bcl-2) and exposed them to hyperoxia. Bcl-2 did not hinder hyperoxia-induced mitochondria and DNA oxidative damage of type II cell in vivo. Accordingly, lung damage was identical in both Tg-Bcl-2 and littermate mice strains, as measured by lung weight, bronchoalveolar lavage, and protein content. Nevertheless, we observed a significant lower number of TUNEL-positive cells in type II cells isolated from Tg-Bcl-2 mice exposed to hyperoxia compared with cells isolated from littermate mice. In summary, these results show that although Bcl-2 overexpression is able to prevent hyperoxia-induced cell death at single cell level in vitro and ex vivo, it is not sufficient to prevent cell death of parenchymal cells and to protect the lung from acute damage in mice. apoptosis; oxidative stress; epithelial type II cells; MLE12; transgenic mice EXPOSURE TO HIGH OXYGEN CONCENTRATION and mechanical ventilation are often used to maintain an adequate blood oxygenation in preterm babies and adults suffering from acute lung injury (ALI) (25, 41). However, prolonged oxygen treatment is toxic and characterized by increased reactive oxygen species (ROS) production leading to subsequent diffuse alveolar damage, disruption of the alveolo-capillary barrier, and exudation of plasma into the alveolar space. Alveolar leak occurs when endothelial and epithelial cells are damaged, suggesting that both these cells are crucial to maintain the tightness of the alveolo-capillary barrier (5).
EXPOSURE TO HIGH OXYGEN CONCENTRATION and mechanical ventilation are often used to maintain an adequate blood oxygenation in preterm babies and adults suffering from acute lung injury (ALI) (25, 41) . However, prolonged oxygen treatment is toxic and characterized by increased reactive oxygen species (ROS) production leading to subsequent diffuse alveolar damage, disruption of the alveolo-capillary barrier, and exudation of plasma into the alveolar space. Alveolar leak occurs when endothelial and epithelial cells are damaged, suggesting that both these cells are crucial to maintain the tightness of the alveolo-capillary barrier (5) .
In vitro, pulmonary cells exposed to high oxygen concentration present DNA, lipids, and proteins damages, resulting in cell dysfunction and ultimately cell death (10, 33, 48) . Cells exhibit morphological features of apoptosis or necrosis depending on the cell type (9, 18, 37, 44) . During oxygen exposure, mitochondria actively increase their production of intracellular ROS (13) and play a pivotal role in the regulation of cell death response. They control the intracellular ATP level and release death promoting factors, such as the cytochrome c and the apoptosis-inducing factor (6, 23) . We showed in a previous study that hyperoxia alters the mitochondrial morphology and induces Bax translocation and cytochrome c release in mouse lung (35) . Bucellato et al. (8) demonstrated that ROS are responsible for hyperoxia-induced Bax translocation to mitochondria and consequent mitochondria-dependent signaling pathway of apoptosis in primary rat alveolar cells. Moreover, the authors showed that hindering this pathway by the overexpression of the anti-apoptotic member of the Bcl-2 family, Bcl-XL, protects cells from hyperoxia-induced death (8, 9) . Similarly, cells derived from Bax-BakϪ/Ϫ animals were protected from oxygen-induced cell death. All this evidence highlights the importance of the mitochondria-dependent cell death pathway in hyperoxia (9) . The anti-apoptotic molecule Bcl-2 exerts its action principally at the mitochondrial level. It is able to block the release of proapoptotic factors by avoiding the opening of the mitochondrial permeability transition pore and Bax oligomerization (14, 51) . It also prevents oxidative stress by influencing the cellular antioxidant capacity (17, 22, 29) . In vivo, Bcl-2 decreases oxidative stress in different pathological models, such as ischemia or sepsis. Its overexpression in neurons diminishes vaso-occlusive cerebralinduced cell death (26) and inhibits reperfusion injury (7, 39) . Furthermore, liver and gut of mice overexpressing Bcl-2 are protected from LPS and Fas-induced damage (19, 43) . In all experimental models described, the protective mechanisms advocated have been related to a decrease in cell death. Similarly, the higher survival rate during hyperoxia exposure of mice overexpressing IL-6 in Clara cells has been correlated with higher levels of Bcl-2 in the lungs (49) .
We recently reported that the overexpression of Bcl-2 protects a fibroblastic cell line (L929 cells) from hyperoxiainduced cell death by interfering with the mitochondria-dependent apoptotic-signaling pathway and by increasing the level of GSH (29) . In the present study, we demonstrated that Bcl-2 overexpression in a murine epithelial type II cell line (MLE12) leads to a significant decrease of hyperoxia-induced cell death comparable to fibroblast cell lines. We therefore raised the question of whether the specific overexpression of Bcl-2 in lung epithelial type II cells could protect mice from hyperoxiainduced lung injury. To this purpose, we generated transgenic mice overexpressing Bcl-2 under the control of SP-C promoter (Tg-Bcl-2) and we exposed them to hyperoxia. We showed that Bcl-2 overexpression decreased cell death in isolated type II cells but does not prevent hyperoxia-induced acute lung injury.
MATERIALS AND METHODS

Generation of Transgenic Mice
The SP-C-hBcl-2-GFP construct was obtained by sequential cloning. The coding sequence of human bcl-2 gene derived from previous studies (42) , flanked by the ␤-globin intron and the poly-adenylation sequence (polyA) of the ␤-globin gene, was digested from the construct PKK1 (Khatib K and Rodriguez I, unpublished observations) by XbaI and KpnI and subcloned into the SmaI cut pucSP-C vector (30) . The resulting construct, named PEKK1, contained the SP-C promoter (3.7 kb, sequence from Ϫ3559 to Ϫ151), followed by the ␤-globin intron, the coding sequence of hBcl-2 gene, and the polyA of the ␤-globin gene.
To monitor the tissue expression of the hBcl-2 transgene, we generated a polycystronic construct containing the above-mentioned elements followed by an initial ribosomal entry site (IRES), the bovine tau, and the green fluorescence protein coding sequence (tau:GFP). A fragment containing the IRES-tau:GFP sequence was obtained by EcoRI-XbaI digestion of pITGNL vector (42) and inserted into a pbluescript II vector, having a modified multicloning site and the polyA of the ␤-globin gene (PEKK2). This new construct was named PEKK3-GFP. Thereafter, an EcoRI-SacI fragment of PEKK1, corresponding to the SP-C promoter and the ␤-globin intron sequence, was inserted into PEKK3-GFP to obtain PEKK4-GFP construct (SP-C promoter, intron of the ␤-globin gene, IRES tau:GFP polyA sequence). Finally, the coding sequence of hBcl-2 gene of pEKK1 was digested by EcoRI and inserted in EcoRI-digested PEKK4-GFP to obtain the final construct SP-C-hBcl-2-GFP containing SP-C promoter, the intron of the ␤-globin gene, the coding sequence for the hBcl-2 gene, the IRES tau:GFP sequence, and the polyA sequence (PEKK5-GFP). The complete transgene was excised by digestion of PEKK5-GFP with XhoI, gel purified, and microinjected into C57BL6xCBA F1 oocytes. Founder lines were identified by PCR of genomic DNA from tails of mice.
Primers corresponding to the hBcl-2 sequence: 5=-CTTCGC-CGAGATGTCCAG-3= and 5=-TTGGGGCAGTGTTGA-3=; the GFP sequence: 5=-GACGTAAACGGCCACAAGTTC-3= and 5=-GTCGC-CGAACTTCACCTC-3=; the polyA sequence of the ␤-globin gene: 5=-AATTCATCTCAGG-3= and 5=-TCATGGCAGCCATATGG-3=, were used.
Positive founders were mated with C57BL6 mice up to the sixth generation. To confirm overexpression of hBcl-2 gene, quantitative RT-PCR was performed on total lung extract. Protein expression was then studied by Western blot (WB) and by immunohistochemistry (IHC).
In Vivo Hyperoxia Experiments
The study was performed with 8-to 10-wk-old female mice weighing 20 -25 g, bred in a conventional animal facility. Littermate and Tg-Bcl-2 mice were placed in a sealed plexiglas chamber and exposed to 100% O 2 for 72 h, as previously described (2) . Control mice were exposed to room air in the same conditions. After death, lung damage was macroscopically evaluated, according to the extension of hemorrhage. A score ranging from 0 (no lesions) to 5 (complete hemorrhagic lung) was given by three independent examiners (35) . Pulmonary edema was evaluated, as previously described (2, 3). The right lung was weighed, immediately frozen in liquid nitrogen, and stored at Ϫ80°C, until further analysis. The left lung was fixed in 4% formalin and stored for histological analysis. The measurement of pulmonary edema was performed in separate experiments: 0.7 ml of PBS was intratracheally instilled, and bronchoalveolar lavage fluid (BALF) was performed and recovered immediately on ice. After centrifugation, cells were counted, and protein concentration was determined as previously reported (3, 4) . All study protocols were approved by the local ethical committee on animal experiments (Office Vétérinaire Cantonal of Geneva, Switzerland).
Immunohistochemistry and Electron Microscopy Analysis
Formalin fixed lungs were embedded in paraffin. Tissue sections of 5 m were cut and mounted on slides pretreated with 3-aminopropylxylane (Merck, Darmstadt, Germany), baked overnight at 55°C, deparaffinized, and rehydrated. Sections were cooked 3 ϫ 5 min in a microwave to facilitate the access to the antibody. After cooling, samples were blocked with 5% BSA in Tris-buffered solution (TBS) and incubated with 1) rabbit polyclonal anti-ProSurfactant protein C antibody (dilution 1:250; Chemicon), 2) rabbit polyclonal anti-human Bcl-2 antibody (dilution 1:150; BD Pharmingen), or 3) rabbit polyclonal anti-GFP (1:100, A1122 Invitrogen). As secondary antibody, goat anti-rabbit FITC-conjugated (dilution 1:500; Jackson) and goat anti-rabbit Texas Red-conjugated (dilution 1:250, Molecular Probes) antibodies were used. The nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) (dilution 1:500; Roche Diagnostic). Slides were mounted with Mowiol 4-88 (Sigma-Aldrich) and analyzed by confocal microscopy (LSM 510 Meta, Zeiss).
TUNEL Staining
TUNEL was performed on an OCT-fixed mouse lung cryosection of 5 m according to the protocol of the In Situ Cell Death Detection Fluorescein kit (Roche). Briefly, lung slides were fixed with 4% PAF for 10 min at room temperature and then permeabilized for 2 min on ice with 0.1% Triton X-100 in 0.1% sodium citrate freshly prepared. Slides were then incubated with the labeling mixture for 1 h at 37°C, and then with a rabbit polyclonal anti-SPC antibody (dilution 1:250; Chemicon). As secondary antibody, we used a goat anti-rabbit FITC conjugated (dilution 1:500; Jackson), and finally stained with DAPI. Slides were then mounted with Fluorescent Mounting Media (Calbiochem). Images were acquired by confocal microscopy (LSM 510 Meta, Zeiss).
Electron Microscopy Analysis
Mouse lungs were instilled intratracheally and fixed in 2.0% glutaraldehyde (in 0.1 M cacodylate buffer) and then embedded in Epon, as previously described (35) . Sections were examined with a Philips CM10 (Philips, Zurich, Switzerland) 400 electron microscope at 70 kV. The quantification of mitochondrial area surface of type II cells, easily recognizable to their localization and to the presence of lamellar bodies, was performed using the Metamorph software and by calculating the area of each mitochondria (Metamorph software V 6.0, Molecular Devices). Fifty pictures of type II cells per mouse and five mice per condition were analyzed (total number of 250 mitochondria analyzed at ϫ10,000 magnification). The results were expressed in arbitrary units (au).
Epithelial Type II Cell Isolation
Murine alveolar epithelial type II cells were isolated from adult mouse (8 -10 wk old) lungs, as described with minor modifications (11) . Lungs were inflated with dispase (BD Pharmingen) to collapse and then placed in 1 ml of dispase while gently agitated at room temperature for 45 min. Lungs were minced to ϳ1-mm pieces and resuspended in 2 ml of dispase containing collagenase (2 g/ml) and DNase I (Sigma) (50 g/ml). Digested lungs were resuspended in DMEM and 10% FCS and sequentially filtered through 70-, 40-, and 20-m filters. Cells underwent negative selection using biotinylated anti-CD45 and anti-CD16/32 antibodies (BD Pharmingen) and then separated by streptavidin-coated biomagnetic particle system (Dynabeads, Invitrogen). Typically, 1 ϫ 10 6 cells containing 90 -95% type II pneumocytes, as assessed by anti-SP-C staining, were isolated from a single mouse, consistent with previous reports (11) .
Isolated primary pulmonary type II cells were cultured on chamber slides coated with Matrigel, supplemented with 5% collagen type I and 25% SABM (Cambrex). Cells were maintained with 10% FCS and 10 ng/ml KGF in a 37°C incubator, and the media was replaced 1 day before hyperoxia exposure. Cells were placed in sealed glass chambers filled with 95% O 2-5% CO2 at 37°C up to 72 h, as previously done (37) . Normoxic cells were kept in air (21% O2-5% CO2) at 37°C. Medium and gases were replaced every 2 days.
Cell Culture, Transfection, and In Vitro Hyperoxia Experiments
Murine lung epithelial cells (MLE12) were grown in DMEM and 1,000 mg/l glucose (Sigma-Aldrich), supplemented with 1% penicillin-streptomycin (Gibco) and 10% FCS. MLE12 cells were stably transfected with a pIRES2-EGFP vector (BD Bioscience) either empty (neo cells) or containing the human Bcl-2 coding sequence (Bcl-2 cells). Transfection was performed by liposomal-based technique (TansIT-LT1, Mirus). The Bcl-2 overexpression was verified by WB and immunocytochemistry. Experiments were performed in three different clones with similar results.
For hyperoxia experiments, MLE12 were plated at subconfluence (70%) and allowed to adhere 24 h before the experiment. Cells were placed in sealed glass chambers filled with 95% O 2-5% CO2 at 37°C up to 72 h, as previously done (37) . Normoxic cells were kept in air (21% O 2-5% CO2) at 37°C. Medium and gases were replaced every 2 days.
ROS Detection
Cells (1 ϫ 10 4 /well) were plated in clear-bottom 96-wells and washed with DMEM containing no FCS and no phenol red. Cells were then incubated with 5 M 5-(and 6-) chloromethyl-2=,7=-dichlorodihydrofluoresceindiacetate, acetyl ester (CM-H2DFCDA; Molecular Probes) for 1 h at 37°C. After that time, cells were washed again and refed with DMEM containing 0.05% FCS but no phenol red, and exposed to air or hyperoxia until 48 h. Fluorescence emission was measured by a benchtop scanning fluorometer (FlexStation II; Molecular Devices, Bucher Biotec, Basel, Switzerland). Values are expressed as fold increase of fluorescence intensity (a.u.) relative to the values obtained for air-exposed neo cells.
Western Blot Analysis and Immunocytochemistry
Total lung and cell protein extracts were prepared as previously described (29, 35) . For the analysis of type II pneumocyte protein expression, cell extracts were obtained after cell isolation from normoxic or hyperoxic mice. Thirty micrograms of total protein extracts were run on a 12% SDS-polyacrylamide gel and blotted onto nitrocellulose membranes (Amersham International, Amersham, UK). Membranes were blocked overnight in TBS-Tween buffer (0.2 M Tris, pH 7.6, 1.5 M NaCl, 0.1% Tween 20) and 5% milk and incubated with an anti-hBcl-2-specific monoclonal antibody (dilution 1:500; BD Pharmingen) followed by incubation with a horseradish peroxidase-conjugated anti-mouse antibody (dilution 1:3,000, BioRad Laboratories). Fig. 2 . SP-C-hBcl-2-GFP construct and tissue expression. A: transgene construction used to generate Tg-Bcl-2 mice. B: Western blot for hBcl-2 of total kidney, lung, and isolated type II epithelial cells derived from littermate and Tg-Bcl-2 mice (30 g of protein). Anti-␤-actin antibody was used as control of protein loading. One representative experiment is shown. C: immunolocalization on tissue section was performed with an anti-hBcl-2 (green), an anti-SP-C (red), and DAPI (blue), and analyzed by confocal microscopy, ϫ63 magnification. D: immunofluorescence on primary epithelial type II cells of both strains. Cells were stained with an anti-hBcl-2 antibody (green), anti-SP-C antibody (red), and DAPI (blue), and analyzed by confocal microscopy, ϫ63 magnification. Note the colocalization of SP-C and Bcl-2 in epithelial type II cells derived from Tg mice.
Localization of hBcl-2 and SP-C was detected from normoxia-or hyperoxia-exposed animals (72 h) on isolated type II cells. Cells were isolated, cytospinned, and labeled with anti-SP-C (dilution 1:250; Chemicon) and anti-hBcl-2 antibodies (dilution 1:150; BD Pharmingen). As secondary antibody, goat anti-rabbit FITC conjugated (dilution 1:500; Jackson) and goat anti-rabbit Texas Red conjugated (dilution 1:250, Molecular Probes) antibodies were used and finally stained with DAPI (1:500; Roche Diagnostic). Slides were finally mounted with Mowiol, and images were acquired by confocal microscopy (LSM 510 Meta, Zeiss).
Determination of Cell Death
LDH release in cell culture. Lactate dehydrogenase (LDH) was measured as previously described (37) . The release of LDH was calculated as the ratio of extracellular to total (extracellular ϩ intracellular) LDH content (mean of triplicates Ϯ SD), and values were expressed as the percentage of total releasable LDH.
Flow cytometry. Cells were washed in PBS and incubated with annexin V-FITC and propidium iodide according to the manufacturer's instructions (BD Bioscience-Pharmingen and Sigma Aldrich). The analysis was performed with a FACS-SCAN flow-cytometer (BD Bioscience-Pharmingen).
TUNEL assay on primary isolated type II cells. Isolated type II cells from both normoxic mouse strains were cultured on matrigel, as described above. After hyperoxia exposure, TUNEL was performed as described by the manufacturer (TUNEL assay fluorescent kit, Roche). Briefly, type II cells were fixed with 4% PAF for 1 h at room temperature and then permeabilized for 2 min on ice with 0.1% Triton X-100 in 0.1% sodium citrate freshly prepared. Cells were incubated with the labeling mixture for 1 h at 37°C and stained with DAPI and anti-SP-C antibody. Slides were then mounted with Mowiol as described previously. Images were acquired by confocal microscopy (LSM 510 Meta, Zeiss).
Caspase-3 activity measurement. Cells (1 ϫ 10 6 condition) were collected, washed in PBS, and resuspended in hypotonic buffer containing 25 mM HEPES, 5 mM MgCl2, 1 mM aprotinin, 1 mM EDTA, and 1 mM Pefabloc. Protein content was measured using a BCA protein assay kit (Pierce, Rockford, IL). For the caspase activity Fig. 3 . Regulation of hBcl-2 expression in hyperoxic lungs. A: representative Western blot was performed in total lung lysates (30 g) derived from littermate and Tg-Bcl-2 mice exposed to air or hyperoxia for 72 h (Hox). Anti-␤-actin antibody was used as control of protein loading. Left and right panels represent 2 nonadjacent regions of the same Western blot. B: analysis of hBcl-2 expression on lung sections of hyperoxiaexposed mice by confocal microscopy. Immunolocalization was performed as described in Fig. 2 . C: analysis of hBcl-2 expression on isolated type II epithelial cells under hyperoxic condition. Immunolocalization was performed as described in Fig. 2 . Note that Bcl-2 expression was still present at 72 h of hyperoxia. measurement, proteins (20 -60 g) suspended in 20 l of buffer were distributed in a black microclear-bottom 96-well plate (Greiner BioOne, Frickenhausen, Germany). A mix (180 g) containing 10 mM HEPES, 0.1% dimethylammonio-l propanesulfonate, 1% saccharose, 5 mM DTT, and 30 M of the specific substrate for caspase-3 coupled to a fluorochrome (DEVD-AFC, stock at 12.5 mM in DMSO) was added to the sample. The accumulation of the fluorescent product (360-nm excitation/530-nm emission) was recorded during 3 h using a benchtop scanning fluorometer (FlexStation II; Molecular Devices). Analysis of the data was performed using SoftMax Pro and Excel software.
Statistical Analysis
For all parameters measured, the values for all samples in different experimental conditions were averaged, and the SD or SE was calculated. The significance of differences between the values of the groups was determined with unpaired Student's t-test. When appropriate, two-way ANOVA with multiple comparisons was performed.
RESULTS
Bcl-2 Overexpression Protects MLE12 Cells From Hyperoxia-Induced Apoptosis
We stably transfected the murine epithelial cell line MLE12 with an expression vector containing the human sequence of the Bcl-2 cDNA (Bcl-2), or the empty vector (neo), and we exposed them to hyperoxia for 72 h. The overexpression of Bcl-2 in MLE12 was verified by WB (data not shown). Bcl-2 overexpression significantly decreased hyperoxia-induced cell death, as shown by the measure of intracellular LDH release (Fig. 1A) . Interestingly, the overexpression of Bcl-2 also reduced death (LDH release) in hyperoxia-exposed A549 cells (data not shown). MLE-12 cells are known to die by apoptosis when exposed to hyperoxia (8, 44) . We analyzed apoptosis by flow cytometry analysis (FACS), after labeling cells with annexin V and propidium iodide (Fig. 1B) . Hyperoxia increased the percentage of single annexin-V-positive cells (early apoptotic cells) in neo cells (35.8% in hyperoxia-exposed cells vs. 5.3% in normoxia-exposed neo cells, P Ͻ 0,001). The number of early apoptotic cells was significantly decreased in Bcl-2-overexpressing cells compared with neo cells (12.4% in Bcl-2 cells vs. 35 .8% in neo cells at 72 h of hyperoxia, P Ͻ 0.01). To further analyze the cell death signaling pathway, we measured the caspase-3 enzymatic activity in air and in hyperoxic conditions (15, 47) . In neo cells, a fourfold significant increase in caspase-3 activity was observed during hyperoxia, which was significantly reduced by Bcl-2 overexpression (Fig.  1C) . It has been proposed that Bcl-2 can increase intracellular basal levels of ROS, and, by this way, modify the antioxidant capacity of the cells. Similar to our previous results with the murine fibrosarcoma cell line L929, we did not find any difference in basal levels of ROS and in response to hyperoxia between Bcl-2 and neo cells (Fig. 1D) . These results demonstrate that Bcl-2 is able to decrease cell death and in particular apoptosis in murine epithelial cells exposed to hyperoxia.
Generation of Transgenic Mice Specifically Overexpressing hBcl-2 in Epithelial Type II Cells
To investigate whether the specific overexpression of Bcl-2 in alveolar epithelial cells is able to prevent oxygen damage in vivo, we generated mice overexpressing the human Bcl-2 molecule in epithelial type II cells, under the control of the surfactant protein (SP-C) promoter ( Fig. 2A) . Tg-Bcl-2 mice had normal lung architecture, as observed by immunohistology (data not shown). Indeed, Bcl-2 overexpression did not modify the number of type II cells in lung alveoli, as showed by the quantification of SP-C-positive cells on lung sections after immunolabeling with a specific anti-SPC antibody (littermate 16.3 Ϯ 8.1%, Tg-Bcl-2 17.9 Ϯ 7.4%, P ϭ not significant). Moreover, the number of lamellar bodies analyzed by electron microscopy was not different between Tg-Bcl-2 and littermate type II cells (data not shown).
Lung epithelial cell-specific expression was verified by several techniques. Lung promoter specificity was analyzed by RT-PCR on different organs, confirming the exclusive lung targeting of the SP-C promoter (not shown). Human Bcl-2 protein expression was assessed by WB in total lung extracts of Tg-Bcl-2 mice, in others organs, and in isolated type II cells (Fig. 2B ). Its specific localization was shown by confocal microscopy after staining lung sections and isolated type II cells with an anti-hBcl-2 and an anti-SP-C antibody-specific antibody (Fig. 2, C and D, respectively) . We also verified Bcl-2 coexpression by staining lung sections with an anti-GFP and anti-SPC, which gave similar results (data not shown). We found the same amount of double-positive cells: 88.5% for SP-C and Bcl-2 and 88.9% for SP-C and a GFP. Together, these results account for a specific and wide expression of Bcl-2 transgene in lung epithelial type II cells. 
Human Bcl-2 Expression Is Maintained During Hyperoxia in Lung and Epithelial Type II Cells of Tg-Bcl-2 Mice
It has been reported that the SP-C protein levels decrease during oxygen exposure in cultured type II cells and in the lungs at late time points of exposure (45) . To verify whether Bcl-2 expression was maintained during hyperoxia in Tg-Bcl-2 mouse lungs, we exposed Tg-Bcl-2 and littermate to hyperoxia for 72 h and analyzed hBcl-2 expression by WB and IHC. Hyperoxia did not alter the level of hBcl-2 protein in total lung extracts from Tg-Bcl-2 (Fig. 3A) . These results were confirmed by IHC on lung sections and in isolated type II cells cultured in hyperoxia (Fig. 3, B and C) .
Bcl-2 Overexpression in Epithelial Type II Cells Does Not Attenuate DNA and Mitochondria Damage In Vivo
To investigate whether overexpression of Bcl-2 prevents cell death during hyperoxia, we first examined in situ DNA strand breaks by fluorescent TUNEL staining in SP-Cpositive type II cells on lung section from hyperoxiaexposed Tg-Bcl-2 and littermate mice. Hyperoxia increased Fig. 5 . Electronic microscopic aspect of mitochondria in epithelial type II cells. A: mice were exposed to air or to hyperoxia for 72 h, and lung sections were prepared for electronic microscopy. In air conditions, mitochondria of type II cells were electron dense, compact, and presented organized cristae (insets, A and B). After oxygen exposure, mitochondria were swollen and round shaped, and cristae appeared disrupted (insets, C and D) in both mice strains. Magnifications, ϫ10,000 and insets ϫ25,000. B: quantification of the mitochondrial area was determined by measuring the area of each mitochondria of type II cells seen in the images with Metamorph software. Values are expressed in arbitrary units, means Ϯ SD, † †P Ͻ 0.01 air vs. Hox, n ϭ 5 mice/ group, around 50 type II cells for each mouse analyzed.
significantly the number of TUNEL-positive cells in the lungs of Tg-Bcl-2 and littermate mice compared with airexposed animals. However, the number of SP-C-positive and TUNEL-positive cells was similar in Tg-Bcl-2 and littermate mice in hyperoxic conditions (Fig. 4A ). To better understand the different effect of Bcl-2 overexpression between in vitro and in vivo conditions, we isolated primary type II cells from Tg-Bcl-2 and littermate mice, and we subsequently cultured them in hyperoxia for 72 h (Fig. 4B) . Interestingly, in type II cells derived from Tg-Bcl-2 mice, we found significantly less TUNEL-positive cells compared with littermate-derived cells. This suggests that Bcl-2 had a protective effect only ex vivo. We also evaluated the effect of Bcl-2 overexpression on oxygen-induced mitochondrial damage of epithelial type II cells. Mitochondrial aspect of type II cells and their area were analyzed by electron microscopy in air-and hyperoxia-exposed lung sections of both mouse strains. In air, mitochondria of both strains were similarly electrodense. After 72 h of oxygen exposure, we observed swollen mitochondria with cristae disruption in both mice strains (Fig. 5A) . Quantification of the mitochondria area confirmed that hyperoxia increased equally the mitochondria area of Tg-Bcl-2 and littermate mice alveolar type II cells (Fig. 5B) . Together, these observations suggest that Bcl-2 overexpression is not able to prevent cell death in vivo, but it has a protective effect ex vivo on isolated cells.
Bcl-2 Overexpression in Epithelial Type II Cells Is Not Sufficient to Decrease Hyperoxia-Induced Lung Injury
Lung damage was assessed in both groups of mice, according to previously described protocols. As reported in Table 1 , macroscopical examination of lungs showed the same hemorrhage extent in Tg-Bcl-2 compared with littermate mice. Accordingly, right lung weight, BALF protein content, and the BALF cell number were similar in both mice groups after hyperoxic exposure (Table 1) . Lung histology of Tg-Bcl-2 mice exposed to oxygen showed the same extent of alveolar septa thickening and hyaline membrane deposits as littermate animals (data not shown). These data confirm that Bcl-2 overexpression in type II cells is not sufficient to prevent the alveolo-capillary barrier damage.
DISCUSSION
In this study, we reported that the overexpression of Bcl-2, an anti-apoptotic molecule mainly present in mitochondria, is able to decrease epithelial cell death during hyperoxia exposure in a murine epithelial cell line (MLE-12) and in isolated lung type II cells.
We confirmed that hyperoxia induces apoptosis in MLE12 cells, as we previously showed for L929 cells (8, 12, 29) . Programmed cell death was efficiently counteracted by Bcl-2 overexpression in both MLE12 and L929 cells (29) . Interestingly, A549 cells, which are known to die by necrosis in hyperoxic conditions, were also protected by oxygen-induced cell death, when transfected with a Bcl-2 cDNA (data not shown, Ref. 48) . This suggests that Bcl-2 is able to hinder oxidative stress and cell death, whatever is the final issue of the cell type (27) .
We generated transgenic mice expressing Bcl-2 in pulmonary epithelial type II cells. By this approach, we aimed to protect the epithelial side of the alveolo-capillary barrier. Indeed, after pulmonary injury, epithelial type II cells actively participate in the repair of the epithelial layers, by proliferating and differentiating in epithelial type I cells (1, 28, 31, 46) . A protective role for Bcl-2 in hyperoxia was formerly suggested, showing that longer survival to oxygen exposure of mice overexpressing IL-6 in Clara cells correlated with increased Bcl-2 levels within the lung (49) , in particular by activation of PI3K/AKT pathway (21) . This hypothesis was corroborated by in vitro results published by us and others (8, 29) showing that the overexpression of the anti-apoptotic Bcl-x and Bcl-2 molecules hinders hyperoxiainduced apoptosis and cell death. Indeed, ROS generation can activate Bax translocation to the mitochondrial membrane leading to cytochrome c release and cell death. Anti-apoptotic Bcl-2 family members by inactivating Bax can rescue the cells during oxidative stress (8) .
Bcl-2 overexpression was able to decrease DNA damage only in isolated epithelial type II cells exposed to hyperoxia, as observed by TUNEL assay. In vivo, when type II cells were analyzed in lung sections, we were not able to find a significant difference in the number of SP-C-TUNEL-positive cells between Tg-Bcl-2 and littermate mice. Similarly, the mitochondria of alveolar type II cells of Tg-Bcl-2 lungs were not protected from oxygen-induced damage. In accordance of these observations, the overexpression of Bcl-2 was not sufficient to hinder the alveolo-capillary leakage and pulmonary edema, as attested to by the analysis of lung hemorrhage extent, lung weight, and BALF protein content. Several hypotheses can be suggested to explain the lack of protection in acute lung injury:
1) It is interesting to notice that Bcl-2 overexpression was able to protect type II cells exposed to hyperoxia ex vivo similarly to MLE12, but not type II cells when analyzed in vivo. Indeed, culture conditions may change the microenvironment by modifying their susceptibility to apoptosis. Lin et al. (24) showed previously that isolated glial cells overexpressing Bcl-2 were protected from ischemic damage, but In separate experiments, macroscopical score and bronchoalveolar lavage (BAL) were performed by instilling 0.7 ml of PBS. Cells were counted and protein content was measured in the supernatant. The results of 5 experiments are presented as mean values Ϯ SD for each group (n ϭ 14 -33 mice). this was not the case when cocultured or in vivo, suggesting that the presence of gap junctions among cells could abolish the protective effect of Bcl-2 observed in single cells;
2) Alveolar type II cells are very resistant to the hyperoxic damage compared with type I and endothelial cells and actively participate in the repair process (45) . We can hypothesize that targeting Bcl-2 in these cells was not successful since Bcl-2 was insufficient to counterbalance the effects of strong oxidative stress in these stress-resistant cells. According to this point of view, targeting either the endothelium or type I cells might be more successful;
3) One other possible explanation for the lack of protection is the absence of Bcl-2 expression in type I cells (1, 46) . Indeed, our results do not give evidence that Bcl-2 was still present in type I cells. Our data support the hypothesis that, although type I cells are believed to derive from type II cells, they can lose some of their gene expression, which can affect their natural lower resistance against hyperoxic stress. Recently, Waxman and Kolliputi (50) reported that mice treated intratracheally with adenovirus containing a constitutively active form of Bcl-2 were protected in hyperoxia. Indeed, Bcl-2 was taken up by the entire respiratory tract, supporting our results showing that the specific overexpression in type II cells is not sufficient to protect the whole epithelium;
4) Bcl-2-induced protective effect against oxidative stress and subsequent apoptosis has been related to the regulation of the mitochondrial GSH pool (20) . We previously showed that Bcl-2 overexpression can influence the intracellular GSH content, although it does not change significantly the ratio of GSH/GSSG in L929 cells (29) . Interestingly, it has been recently shown that the mitochondrial overexpression of glutathione reductase (GR) was able to rescue cells from hyperoxia-induced cell death (32) . However, the targeted overexpression of GR on epithelial type II cells, although increasing the GSH/GSSG ratio in lungs, was not sufficient to protect mice from hyperoxia-induced injury and inflammation. The authors suggested that compensatory responses to GR expression may play a role such as the modulation of the thioredoxin system (16) . We cannot exclude that this can also occur in our experimental system; 5) Alternatively, additional cellular sources of ROS should be targeted to completely prevent oxygen-induced oxidative stress. Indeed, cells lacking mitochondrial DNA (r0 cells), although presenting attenuation of ROS generation in response to hyperoxia, were not protected against cell death, suggesting that other sources of ROS accounted for cell damage (9) . NADPH oxidase systems could also largely contribute to hyperoxia-induced ROS generation in epithelial type II cells and lung endothelial cells and participate in MLE12 cell death (11, 38, 53) ;
6) The absence of protection could also be accounted for insufficient Bcl-2 expression during hyperoxia. Indeed, some studies reported lower SP-C mRNA and protein expression levels after 48 -72 h of hyperoxia exposure in vivo (40, 45) . However, in our study, Bcl-2 was still present in total lung extracts after 72 h of oxygen exposure. Therefore, it is unlikely that the absence of Bcl-2 protection was related to its reduced expression during hyperoxia exposure. Alternatively, the basal level of Bcl-2 expression obtained in our transgenic mice could be insufficient to prevent the strong hyperoxia-induced oxidative damage. We generated two different founders to perform our experiments, with which we obtained the same results. We cannot exclude that higher Bcl-2-expressing mice are not viable and only milder overexpressing founders would survive. However, the number of newborns and the mendelian distribution obtained do not account for this hypothesis. Alternatively, we also cannot exclude that difference in the expression levels of Bcl-2 among SP-C-positive cells may account for a lower protection; 7) Finally, Bcl-2 overexpression may increase inflammation by influencing the transcription of cytokine, leading to neutrophil pulmonary infiltration, through NF-B modulation (52) . In this perspective, we analyzed the BALF cell number and cytokines (TNF, IL-6) at different time points (48 -96 h), but we were not able to observe any significant difference in cytokine production within these lungs between both mouse groups (data not shown). Experiments performed with TgBcl-2 mice in different models (oxygen and air recovery) did not show any difference in lung lesions (unpublished observations), suggesting that Bcl-2 in vivo may not influence type II cell proliferation (34, 36) .
In summary, these results show that Bcl-2 overexpression in alveolar type II cells can prevent cell death in these specifically targeted cells when cultured ex vivo, but is indeed not sufficient to protect mice from hyperoxia-induced acute lung injury, suggesting that the cell localization and environment play a significant role in hyperoxic lung damage.
